Verastem Inc. (VSTM) was among the biggest gainers on the Russell 2000 for Wednesday January 20 as the stock popped 13.28% to $1.45, representing a gain of $0.17 per share. Some 315,311 shares traded hands on 1,005 trades, compared with an average daily volume of 807,777 shares out of a total float of 36.93 million. The stock opened at $1.25 and traded with an intraday range of $1.47 to $1.24.
After today's gains, Verastem Inc. reached a market cap of $53.56 million. Verastem Inc. has had a trading range between $12.35 and $1.24 over the last year, and it had a 50-day SMA of $1.89 and a 200-day SMA of $5.50.
Verastem Inc is a biopharmaceutical company engaged in discovering and developing proprietary small molecule drugs targeting cancer stem cells along with proprietary companion diagnostics.
Verastem Inc. is based out of Needham, MA and has some 20 employees. Its CEO is Robert Forrester.
For a complete fundamental analysis analysis of Verastem Inc., check out Equities.com’s Stock Valuation Analysis report for VSTM. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.
The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.